PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
19-Nov-2024 Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001 Thermosome
18-Nov-2024 CapeStart Debuts MadeAiā„¢, its GenAI-enabled Platform for Life Sciences that Transforms Literature Review and other Applications CapeStart, Inc.
18-Nov-2024 Iqirvo® (elafibranor) data show efficacy and tolerability for up to 3 years in patients with PBC with improvements in fatigue and pruritus Ipsen
18-Nov-2024 Cure51 launches NHS-approved study with Cambridge University Hospitals and seven other leading UK oncology institutions to unlock cancer survival secrets Cure51
14-Nov-2024 Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer Coronado Research
13-Nov-2024 New Study from Lindus Health Finds Patients are More Likely to Join a Clinical Trial with Telehealth Care Lindus Health
12-Nov-2024 Gifthealth Announces Strategic Partnership with United Digestive Gifthealth
12-Nov-2024 MultiOmic Health announces discovery of novel endotypes and biomarkers for diabetic kidney disease MultiOmic Health
11-Nov-2024 STORM Therapeutics Presents New Clinical Data on its First-in-Class METTL3 Inhibitor STC-15 at SITC 2024 STORM Therapeutics
11-Nov-2024 Resolution Therapeutics Announces New Clinical and Preclinical Data Showcasing Regenerative Macrophage Therapy at AASLD The Liver Meeting® 2024 to Support the Ongoing Phase 1/2 Study for RTX001 in End-Stage Liver Disease Resolution Therapeutics
11-Nov-2024 Ebenbuild Appoints Charles A. Taylor, PhD as Chairman of the Board Ebenbuild
10-Nov-2024 New GMP Training with Certificate Pharma Lessons
07-Nov-2024 PulseSight Therapeutics Presents New Data on PST-611 Transferrin Vectorized Therapy for Geographic Atrophy at EVER Congress 2024 PulseSight Therapeutics
06-Nov-2024 Cambridge Cognition spin-out, Monument Therapeutics, receives £1.0 million for schizophrenia clinical development Cambridge Cognition
05-Nov-2024 Xeltis expands leadership team with appointment of Luc Verhees as Vice President of Clinical Business Development Xeltis
04-Nov-2024 Oak Hill Bio and Chiesi Group Announce First European Patient Enrolled in the Phase 2b Clinical Study Evaluating OHB-607 for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease in Premature Infants Chiesi
01-Nov-2024 Overcollection of data adds months to clinical trials and reduces ROI, finds new Phesi analysis Phesi
01-Nov-2024 Cambridge Cognition announces new data demonstrating effectiveness of proprietary AQUA Cambridge Cognition
01-Nov-2024 PureTech to Present at Two Upcoming Investor Conferences PureTech Health plc
01-Nov-2024 Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study Tiziana Life Sciences